Ticker Details
Allogene Therapeutics, Inc.
IPO Date:	October 8, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$709.39M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.42 | 3.20%
Avg Daily Range (30 D):	$0.12 | 4.94%
Avg Daily Range (90 D):	$0.09 | 4.53%

Institutional Daily Volume
Avg Daily Volume:	1.73M
Avg Daily Volume (30 D):	4.61M
Avg Daily Volume (90 D):	4.52M

Trade Size
Avg Trade Size (Sh.):	158
Avg Trade Size (Sh.) (30 D):	229
Avg Trade Size (Sh.) (90 D):	308

Institutional Trades
Total Institutional Trades:	2,953
Avg Institutional Trade:	$1.85M
Avg Institutional Trade (30 D):	$2.06M
Avg Institutional Trade (90 D):	$1.66M
Avg Institutional Trade Volume:	.19M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.43M
Avg Closing Trade (30 D):	$1.95M
Avg Closing Trade (90 D):	$1.68M
Avg Closing Volume:	245.87K

News

Dec 16, 2025 @ 6:09 PM Allogene Arbitration Victory Pressures Cellectis S... Source: Vandana Singh

Dec 15, 2025 @ 10:39 PM Allogene Therapeutics Reports Favorable Result for... Source: Allogene Therapeutics

Nov 27, 2025 @ 4:00 PM U.S. CAR T-Cell Therapies Market Grows at 30.4% CA... Source: Towards Healthcare

Jul 23, 2025 @ 1:26 PM High‑Growth Oncology Market Projected For U... Source: Prnewswire

Jun 1, 2025 @ 2:45 PM Allogene Therapeutics Provides Updated Phase 1 Dat... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.87	$-.17	$-.87
Diluted EPS	$-.87	$-.17	$-.87
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-190.89M	$-38.81M	$-190.89M
Operating Income / Loss	$-209.32M	$-42.4M	$-209.32M
Cost of Revenue
Net Cash Flow	$-23.53M	$13.87M	$-23.53M
PE Ratio